ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo.

Barbara Mayer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.